Cargando…
Exhaled nitric oxide in diagnosis and management of respiratory diseases
The analysis of biomarkers in exhaled breath constituents has recently become of great interest in the diagnosis, treatment and monitoring of many respiratory conditions. Of particular interest is the measurement of fractional exhaled nitric oxide (FENO) in breath. Its measurement is noninvasive, ea...
Autor principal: | Abba, Abdullah A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801041/ https://www.ncbi.nlm.nih.gov/pubmed/19881162 http://dx.doi.org/10.4103/1817-1737.56009 |
Ejemplares similares
-
Exhaled nitric oxide in stable chronic obstructive pulmonary disease
por: Beg, Mohammed F. S., et al.
Publicado: (2009) -
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases
por: Ragnoli, Beatrice, et al.
Publicado: (2023) -
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
por: Maniscalco, Mauro, et al.
Publicado: (2023) -
Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999) -
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
por: Turner, Steve W., et al.
Publicado: (2019)